Researchers dig into patient histories to uncover clues about macrophage activation syndrome
NCT ID NCT06992505
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study reviewed the medical charts of 32 people with Still's disease who developed a serious complication called macrophage activation syndrome (MAS). The goal was to learn more about their symptoms, how long it took for lab values to return to normal, and what treatments were used. No new drug or intervention was tested; instead, researchers gathered information to better understand the condition and its management.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MACROPHAGE ACTIVATION SYNDROME (MAS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico
Milan, 20122, Italy
-
Ospedale Pediatrico Bambin Gesù
Rome, 00165, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Pandemic stress hits hard for arthritis patients
- New drug combo aims to tame rare inflammatory disease
- 5,000 patients to help unlock secrets of inflammatory heart disease
- New study tracks ilaris use in rare inflammatory diseases across europe
- New study aims to uncover hidden danger in kawasaki disease
- New drug aims to calm dangerous immune storms in Still's and lupus patients